Fulvicin-U/F
Brand names,
Fulvicin-U/F
Analogs
Fulvicin-U/F
Brand Names Mixture
Fulvicin-U/F
Chemical_Formula
C17H17ClO6
Fulvicin-U/F
RX_link
http://www.rxlist.com/cgi/generic3/griseofulvin.htm
Fulvicin-U/F
fda sheet
Fulvicin-U/F
msds (material safety sheet)
Fulvicin-U/F
Synthesis Reference
No information avaliable
Fulvicin-U/F
Molecular Weight
352.766 g/mol
Fulvicin-U/F
Melting Point
220 oC
Fulvicin-U/F
H2O Solubility
8.64 mg/L
Fulvicin-U/F
State
Solid
Fulvicin-U/F
LogP
2.15
Fulvicin-U/F
Dosage Forms
Powder; Tablet
Fulvicin-U/F
Indication
For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi.
Fulvicin-U/F
Pharmacology
Griseofulvin is a mycotoxic metabolic product of Penicillium spp. It was the first available oral agent for the treatment of dermatophytoses and has now been used for more than forty years. Griseofulvin is fungistatic with in vitro activity against various species of Microsporum Epidermophyton, and Trichophyton. It has no effect on bacteria or on other genera of fungi. Following oral administration, griseofulvin is deposited in the keratin precursor cells and has a greater affinity for diseased tissue. The drug is tightly bound to the new keratin which becomes highly resistant to fungal invasions.
Fulvicin-U/F
Absorption
Poorly absorbed from GI ranging from 25 to 70% of an oral dose. Absorption is significantly enhanced by administration with or after a fatty meal.
Fulvicin-U/F
side effects and Toxicity
Side effects are minor: headaches, gastrointestinal reactions and cutaneous eruptions
Fulvicin-U/F
Patient Information
Fulvicin-U/F
Organisms Affected
Yeast and other Trichophyton or Microsporum fungi